Risk assessment and clinical decision making for colorectal cancer screening.

Risk assessment and clinical decision making for colorectal cancer screening.
复制标题

DOI:
10.1111/hex.12110
复制
发表时间:
2015-10
期刊:
Health expectations : an international journal of public participation in health care and health policy
影响因子:
--
通讯作者:
Battaglia TA
Battaglia TA
中科院分区:
其他
文献类型:
--
作者:
Schroy PC 3rd;Caron SE;Sherman BJ;Heeren TC;Battaglia TA

文献摘要

参考文献

被引文献

相似文献

Shared decision-making (SDM) related to test preference has been advocated as a potentially effective strategy for increasing adherence to colorectal cancer screening yet primary care providers (PCPs) are often reluctant to comply with patient preferences if they differ from their own. Risk stratification advanced colorectal neoplasia (ACN) provides a rational strategy for reconciling these differences. To assess the importance of risk stratification in PCP decision-making related to test preference for average-risk patients and receptivity to use of an electronic risk assessment tool for ACN to facilitate SDM. Mixed-methods, including qualitative key informant interviews and a cross-sectional survey. PCPs at an urban, academic safety-net institution. Screening preferences, factors influencing patient recommendations, and receptivity to use of a risk stratification tool Nine PCPs participated in interviews and 57 completed the survey. Despite an overwhelming preference for colonoscopy by 95% of respondents, patient risk (67%) and patient preferences (63%) were more influential in their decision-making than patient comorbidities (31%; P<0.001). Age was the single most influential risk factor (excluding family history), with <20% of respondents choosing factors other than age. Most respondents reported that they would be likely to use a risk stratification tool in their practice either “often” (43%) or sometimes (53%). Risk stratification was perceived to be important in clinical decision-making yet few providers considered risk factors other than age for average-risk patients. Providers were receptive to the use of a risk assessment tool for ACN when recommending an appropriate screening test for select patients.
DOI: 10.1002/cncr.26551
发表时间: 2012-05-15
期刊: Cancer
影响因子: 6.2
作者:
Hawley ST;McQueen A;Bartholomew LK;Greisinger AJ;Coan SP;Myers R;Vernon SW
通讯作者: Vernon SW
DOI: 10.1111/j.1525-1497.2005.00164.x
发表时间: 2005-11-01
影响因子: 5.7
作者:
Denberg, TD;Melhado, TV;Ahnen, DJ
通讯作者: Ahnen, DJ
DOI: 10.7326/0003-4819-139-12-200312160-00005
发表时间: 2003-12-16
影响因子: 39.2
作者:
Imperiale, TF;Wagner, DR;Ransohoff, DF
通讯作者: Ransohoff, DF
DOI: 10.1046/j.1369-6513.2000.00093.x
发表时间: 2000-09-01
期刊: Health expectations : an international journal of public participation in health care and health policy
影响因子: --
作者:
Holmes-Rovner, Margaret;Valade, Diane;Keiser, Susan
通讯作者: Keiser, Susan
DOI: 10.1016/s0277-9536(99)00145-8
发表时间: 1999-09-01
影响因子: 5.4
作者:
Charles, C;Gafni, A;Whelan, T
通讯作者: Whelan, T